CAPR News

Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12

Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12

Exosome Diagnostic and Therapeutics Market to Reach USD 401.70 Million by 2032 Amid Rapid Advances in Liquid Biopsy, Precision Medicine, and Exosome-Based Drug Delivery - Credence Research

Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference

Capriotti's Opens Second Oahu Location in Kapolei on February 10

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)

Capriotti's Serves Up High-Protein Subs Packed with Bold Flavor

RightBRIDGE Launches RightBRIDGE Annuity Book Management, a Revolutionary System for Annuity Life Cycle Management

RightBRIDGE Launches RightBRIDGE Annuity Book Management, a Revolutionary System for Annuity Life Cycle Management

Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data